{
    "root": "a1344411-fc64-4233-89ba-e90a1953e150",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Carvedilol",
    "value": "20250301",
    "ingredients": [
        {
            "name": "CARVEDILOL",
            "code": "0K47UL67F2"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Carvedilol Tablet is an alpha/beta-adrenergic blocking agent indicated for the treatment of: • Mild to severe chronic heart failure ( 1.1 ) • Left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) • Hypertension ( 1.3 )",
    "contraindications": "Carvedilol Tablet should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.",
    "warningsAndPrecautions": null,
    "adverseReactions": "Carvedilol Tablet is contraindicated in the following conditions:\n                  \n                     \n                        •\n                        Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of Carvedilol Tablet.\n                     \n                     \n                        •Second- or third-degree AV block\n                     \n                        •Sick sinus syndrome\n                     \n                        •Severe bradycardia (unless a permanent pacemaker is in place)\n                     \n                        •Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating Carvedilol Tablet.\n                     \n                        •Patients with severe hepatic impairment\n                     \n                        •Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol."
}